7 results on '"Waluś-Miarka, Małgorzata"'
Search Results
2. Serum PCSK9 Correlates with PTX3 and Apolipoproteins B, A1, and C3 Concentrations in Patients with Type 2 Diabetes.
- Author
-
Waluś-Miarka, Małgorzata, Kapusta, Maria, Miarka, Przemysław, Kawalec, Ewa, and Idzior-Waluś, Barbara
- Subjects
- *
TYPE 2 diabetes , *APOLIPOPROTEIN A , *APOLIPOPROTEINS , *APOLIPOPROTEIN E4 , *CARDIOVASCULAR diseases risk factors - Abstract
Proprotein convertase subtilisin/kexin type 9 (PCSK9) is involved in the regulation of LDL metabolism. There is evidence that circulating PCSK9 is a cardiovascular risk factor. In this study, we determined factors associated with circulating PCSK9 in a group of patients with type 2 diabetes mellitus (DM2). Material included 116 consecutive patients with DM2 from outpatient diabetes clinic. Circulating PCSK9, PTX3, apolipoprotein (apo) B100, apo B48, and apo C3 levels were determined by ELISA, apo A1 by immunoturbidimetry. The mean (sd) age of patients was 59.1 (11.1) years, the mean (sd) values of serum PCSK9 were 255.4 (106.97) ng/ml. Circulating PCSK9 correlated negatively with age (r = − 0.21 , p < 0.05) and HbA1c (r = − 0.21 , p < 0.05) and positively with BMI (r = 0.21 , p < 0.05), total cholesterol (r = 0.59), LDL-cholesterol (r = 0.50), triglyceride (r = 0.35), apo B100 (r = 0.43), apo A1 (r = 0.43) (p < 0.001 for all), apo C3 (r = 0.29 , p < 0.01), and apo B48 (r = 0.25 , p < 0.01) concentration and FLI (r = 0.26 , p < 0.01). Strong correlation between PTX3 and PCSK9 levels was observed (r = 0.47 , p < 0.001). Multiple stepwise backward regression analysis with PCSK9 as dependent variable revealed that PTX3, apo B100, apo A1, apo B48, and BMI were significantly positive and the presence of NAFLD and HbA1c negatively associated with PCSK9 concentrations. These variables together explain 57% of PCSK9 variability; the strongest relationship was observed between PCSK9 and PTX3 and apo B100. Our results indicate that circulating PCSK9 is significantly associated with inflammation marker PTX3 as well as atherogenic lipids and apolipoproteins C3, B100, and B48, which might be of value in understanding interactions between development of atherosclerosis and inflammatory state in DM2 patients. [ABSTRACT FROM AUTHOR]
- Published
- 2021
- Full Text
- View/download PDF
3. Correlates of pentraxin 3 serum concentration in men and women with type 2 diabetes.
- Author
-
Waluś-Miarka, Małgorzata, Trojak, Aleksandra, Miarka, Przemysław, Kapusta, Maria, Kawalec, Ewa, Idzior-Waluś, Barbara, and Małecki, Maciej T
- Subjects
- *
TYPE 2 diabetes , *URIC acid , *SERUM , *REGRESSION analysis , *CREATININE - Abstract
Elevated levels of plasma pentraxin 3 (PTX3), a marker of inflammation, are associated with the risk of developing cardiovascular diseases in the general population, as well as in patients with type 2 diabetes (DM2). In this study, we aimed to determine factors associated with PTX3 serum concentrations in men and women with DM2. The study included 116 consecutive patients (67 men and 49 women) with DM2 from an outpatient diabetic clinic. Men were characterised by lower age and higher uric acid, creatinine and bilirubin concentrations and waist/hip ratio than women. In women, low-density lipoprotein cholesterol (LDL-C) levels were higher than in men. In men, median (interquartile range) values of PTX3 concentration were 4.02 (1.99), and in women they were 4.53 (3.31) ng/ml (NS). In men, PTX3 concentrations correlated with total cholesterol (TC), triglycerides, apolipoprotein (Apo) C3, Apo B48, Glc and creatinine levels. In women, PTX3 correlated significantly with TC and LDL-C and Apo B100. Partial regression analysis revealed that after adjusting for age, PTX3 concentrations in men were significantly associated with TC, LDL-C, triglycerides, creatinine, Apo C3 and Apo B48, while in women they were associated with TC, LDL-C and Apo B100. The results could be of importance in sex-specific prevention of vascular complications in DM2 patients. [ABSTRACT FROM AUTHOR]
- Published
- 2020
- Full Text
- View/download PDF
4. Carotid artery plaques – Are risk factors the same in men and women with familial hypercholesterolemia?
- Author
-
Waluś-Miarka, Małgorzata, Czarnecka, Danuta, Kloch-Badełek, Małgorzata, Wojciechowska, Wiktoria, Kapusta, Maria, and Malecki, Maciej T.
- Subjects
- *
CAROTID artery diseases , *HYPERCHOLESTEREMIA , *LOW density lipoproteins , *DISEASES in women , *ALANINE aminotransferase , *ODDS ratio - Abstract
Background and aims High low-density lipoprotein (LDL)-cholesterol levels are a major cause of premature coronary heart disease (CHD) and death in patients with familial hypercholesterolemia (FH). It is uncertain whether these risk factors affect men and women equally. We aimed to compare the risk factors of carotid plaques, which are reliable surrogates of coronary atherosclerosis, in men and women with FH. Methods 154 patients with FH (40.9% men) were included, diagnosed according to Simon Broome criteria. Carotid plaques were assessed by ultrasound. Results In women multiple logistic regression analysis revealed that systolic blood pressure, high-density lipoprotein-cholesterol (HDL-C), apolipoprotein (apo) A1, and alanine aminotransferase (ALT) were associated with the presence of carotid plaques. In this female cohort, the age adjusted odds ratio for the increase of HDL-C by 1 standard deviation was related to a 55% decrease in the odds of having carotid plaques ( p = 0.01) and the age adjusted odds ratio for the increase of ALT by 1 U/L was related to a 7% in the increase odds of having carotid plaques ( p = 0.02). In men, in multiple logistic regression analysis only apo B concentration was significantly related to carotid plaque presence. The odds ratio for the increase of apo B by 1 mg/dl corresponded to a 4% increase in the odds of having carotid plaques ( p = 0.01) and, interestingly, in men not treated with statin, this ratio reached 8% ( p = 0.04). Conclusions In summary, our study suggests a difference in risk factors of carotid artery plaques between men and women with FH. [ABSTRACT FROM AUTHOR]
- Published
- 2017
- Full Text
- View/download PDF
5. Carotid Plaques Correlates in Patients With Familial Hypercholesterolemia.
- Author
-
Waluś-Miarka, Małgorzata, Czarnecka, D., Wojciechowska, W., Kloch-Badełek, M., Kapusta, M., Sanak, M., Wójcik, M., Małecki, M. T., Starzyk, J., and Idzior-Waluś, B.
- Subjects
- *
ATHEROSCLEROSIS , *CAROTID artery , *CONFIDENCE intervals , *ENZYME-linked immunosorbent assay , *RESEARCH funding , *STATISTICS , *T-test (Statistics) , *DATA analysis , *DATA analysis software , *DESCRIPTIVE statistics , *FAMILIAL hypercholesterolemia , *ODDS ratio , *MANN Whitney U Test - Abstract
Patients with familial hypercholesterolemia (FH) are at increased risk of premature cardiovascular disease. We compared factors associated with the presence of carotid plaques and carotid intima–media thickness (cIMT), markers of subclinical atherosclerosis, in 241 patients with FH (98, 40.7% men; mean age 41 ± 18.4 years). Patients with FH having carotid plaques (36.5%) had mean age, apolipoprotein (apo) B, glucose, apoA1, systolic blood pressure (SBP) and diastolic BP, waist/hip ratio (WHR), and body mass index higher than patients without plaques. Logistic regression revealed that apoB (odds ratio [OR] per 1 unit change 1.03, P = .005), high-density lipoprotein cholesterol (HDL-C; OR per 1 standard deviation [SD] change 0.59, P = .015), and non-HDL-C (OR per 1SD change 1.53, P = .04) were significantly associated with the presence of plaques. The cIMT correlated with obesity parameters, BP, apoB, glucose, high-sensitivity C-reactive protein, creatinine, γ-glutamyl transpeptidase, and alanine transaminase (P < .001). Regression analysis revealed that cIMT was significantly associated with apoB, SBP, and WHR. These results confirm the role of apoB-containing lipoproteins and low HDL-C with the presence of carotid plaques and apoB, BP, and WHR with cIMT. [ABSTRACT FROM AUTHOR]
- Published
- 2016
- Full Text
- View/download PDF
6. Osteoprotegerin is associated with markers of atherosclerosis and body fat mass in type 2 diabetes patients
- Author
-
Waluś-Miarka, Małgorzata, Katra, Barbara, Fedak, Danuta, Czarnecka, Danuta, Miarka, Przemysław, Woźniakiewicz, Ewa, Małecki, Maciej, and Idzior-Waluś, Barbara
- Published
- 2011
- Full Text
- View/download PDF
7. Corticosteroid treatment of kidney disease in a patient with familial lecithin-cholesterol acyltransferase deficiency.
- Author
-
Miarka, Przemysław, Idzior-Waluś, Barbara, Kuźniewski, Marek, Waluś-Miarka, Małgorzata, Klupa, Tomasz, and Sułowicz, Władysław
- Subjects
- *
KIDNEY disease treatments , *CORTICOSTEROIDS , *FAMILIAL diseases , *LECITHIN , *ACYLTRANSFERASES , *HIGH density lipoproteins , *RENIN-angiotensin system , *CHOLESTEROL - Abstract
Familial lecithin-cholesterol acyltransferase (LCAT) deficiency (FLD) is a rare genetic disorder of lipid metabolism, characterised by low plasma HDL cholesterol, proteinuria, haemolytic anaemia and corneal opacities. Usually renal disease progresses during the third decade of life to renal failure; however the pathogenesis of renal disease is not well understood. In this study we describe treatment of renal disease in two siblings with FLD. The proband WX at the age of 31 years presented proteinuria and ankle oedema during her third pregnancy. Diagnosis of FLD was based on a renal biopsy with characteristic serpiginous fibrillar deposits under electron microscopy, markedly decreased HDL cholesterol, esterified cholesterol levels and LCAT activity, confirmed by molecular analysis. After 3 years her proteinuria increased and she received an ACE inhibitor to which she responded well. During further increases of proteinuria she additionally received methylprednisolone and her proteinuria decreased. This long-term observation indicates the efficacy of corticosteroids and renin−angiotensin−aldosterone system blockers in the treatment of proteinuria in patients with FLD. The results suggest the role of inflammatory processes as well as dyslipidemia in the pathogenesis of glomerular disorders in LCAT-deficient patients. [ABSTRACT FROM AUTHOR]
- Published
- 2011
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.